Gilead indicated that there were plans to publish the data in a peer-reviewed outlet.[37] On 24 April, WHO released a scientific brief arguing against immunity passports due to insufficient evidence.[38] They also launched Access to COVID-19 tools accelerator, a collaboration to accelerate the development and production of vaccines, diagnostics and therapeutics for COVID-19.[39]